BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 18594325)

  • 1. Analysis of volatile organic compounds in the exhaled breath for the diagnosis of lung cancer.
    Mazzone PJ
    J Thorac Oncol; 2008 Jul; 3(7):774-80. PubMed ID: 18594325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of volatile organic compounds in exhaled breath of patients with lung cancer using solid phase microextraction and gas chromatography mass spectrometry.
    Ligor M; Ligor T; Bajtarevic A; Ager C; Pienz M; Klieber M; Denz H; Fiegl M; Hilbe W; Weiss W; Lukas P; Jamnig H; Hackl M; Buszewski B; Miekisch W; Schubert J; Amann A
    Clin Chem Lab Med; 2009; 47(5):550-60. PubMed ID: 19397483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of the volatile organic compounds exhaled by lung cancer cells in vitro for breath diagnosis.
    Chen X; Xu F; Wang Y; Pan Y; Lu D; Wang P; Ying K; Chen E; Zhang W
    Cancer; 2007 Aug; 110(4):835-44. PubMed ID: 17599760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative breath analysis of volatile organic compounds of lung cancer patients.
    Song G; Qin T; Liu H; Xu GB; Pan YY; Xiong FX; Gu KS; Sun GP; Chen ZD
    Lung Cancer; 2010 Feb; 67(2):227-31. PubMed ID: 19409642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study.
    Poli D; Carbognani P; Corradi M; Goldoni M; Acampa O; Balbi B; Bianchi L; Rusca M; Mutti A
    Respir Res; 2005 Jul; 6(1):71. PubMed ID: 16018807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of lung cancer by the analysis of exhaled breath with a colorimetric sensor array.
    Mazzone PJ; Hammel J; Dweik R; Na J; Czich C; Laskowski D; Mekhail T
    Thorax; 2007 Jul; 62(7):565-8. PubMed ID: 17327260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of lung cancer with volatile markers in the breath.
    Phillips M; Cataneo RN; Cummin AR; Gagliardi AJ; Gleeson K; Greenberg J; Maxfield RA; Rom WN
    Chest; 2003 Jun; 123(6):2115-23. PubMed ID: 12796197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breath testing as a method for detecting lung cancer.
    Taivans I; Bukovskis M; Strazda G; Jurka N
    Expert Rev Anticancer Ther; 2014 Feb; 14(2):121-3. PubMed ID: 24467216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of an Exhaled Breath Monitoring System with Semiconductive Gas Sensors, a Gas Condenser Unit, and Gas Chromatograph Columns.
    Itoh T; Miwa T; Tsuruta A; Akamatsu T; Izu N; Shin W; Park J; Hida T; Eda T; Setoguchi Y
    Sensors (Basel); 2016 Nov; 16(11):. PubMed ID: 27834896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study.
    Westhoff M; Litterst P; Freitag L; Urfer W; Bader S; Baumbach JI
    Thorax; 2009 Sep; 64(9):744-8. PubMed ID: 19158121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human exhaled air analytics: biomarkers of diseases.
    Buszewski B; Kesy M; Ligor T; Amann A
    Biomed Chromatogr; 2007 Jun; 21(6):553-66. PubMed ID: 17431933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive phenotyping using exhaled volatile organic compounds in asthma.
    Ibrahim B; Basanta M; Cadden P; Singh D; Douce D; Woodcock A; Fowler SJ
    Thorax; 2011 Sep; 66(9):804-9. PubMed ID: 21749985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An exploratory comparative study of volatile compounds in exhaled breath and emitted by skin using selected ion flow tube mass spectrometry.
    Turner C; Parekh B; Walton C; Spanel P; Smith D; Evans M
    Rapid Commun Mass Spectrom; 2008; 22(4):526-32. PubMed ID: 18215004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
    Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
    Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An electronic nose in the discrimination of patients with asthma and controls.
    Dragonieri S; Schot R; Mertens BJ; Le Cessie S; Gauw SA; Spanevello A; Resta O; Willard NP; Vink TJ; Rabe KF; Bel EH; Sterk PJ
    J Allergy Clin Immunol; 2007 Oct; 120(4):856-62. PubMed ID: 17658592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exhaled biomarkers in lung cancer.
    Horváth I; Lázár Z; Gyulai N; Kollai M; Losonczy G
    Eur Respir J; 2009 Jul; 34(1):261-75. PubMed ID: 19567608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exhaled breath analysis: novel approach for early detection of lung cancer.
    Chan HP; Lewis C; Thomas PS
    Lung Cancer; 2009 Feb; 63(2):164-8. PubMed ID: 18599152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anodic alumina coating for extraction of volatile organic compounds in human exhaled breath vapor.
    Zhang G; Zou L; Xu H
    Talanta; 2015 Jan; 132():528-34. PubMed ID: 25476340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress in the development of volatile exhaled breath signatures of lung cancer.
    Mazzone PJ; Wang XF; Lim S; Jett J; Choi H; Zhang Q; Beukemann M; Seeley M; Martino R; Rhodes P
    Ann Am Thorac Soc; 2015 May; 12(5):752-7. PubMed ID: 25965541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of accurate classification method based on the analysis of volatile organic compounds from human exhaled air.
    Van Berkel JJ; Dallinga JW; Möller GM; Godschalk RW; Moonen E; Wouters EF; Van Schooten FJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jan; 861(1):101-7. PubMed ID: 18055279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.